NOS3 and neoplasm: Early studies in the 1990s first linked NO to tumor angiogenesis (e.g., via eNOS-mediated vascular dilation), yet subsequent work revealed conflicting roles: low NO concentrations drive tumor cell proliferation and immune evasion, while high NO/ONOO− levels induce DNA damage and apoptosis – a duality that has long perplexed researchers [1].